Calumet, Inc.
NASDAQ:CLMTOil & Gas Exploration & Production
-$1.21 today
- Market cap
- $2.67B
- Beta
- 0.72
- P/E (TTM)
- -14.7
- EPS (TTM)
- -$2.17
Volume 1.74M
Average 1.11M
CLMT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Calumet, Inc.NASDAQ: CLMT
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA declines year over year
Q3 FY2026 EBITDA of $332.7M fell 3.4% year over year, ahead of the -113.4% change in trailing-twelve-month EBITDA. Over 3 fiscal years it compounded at +31.7% a year.
Context
- EBITDA amounted to 5.8% of revenue in FY2025, up 1.8 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $288.39M (+21.0%) for the fiscal year ending Dec 2026, a slowdown from the +44.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $332.7M+1190.8% QoQ
- Last fiscal yearDec 2025
- $238.4M+44.9% YoY
- LTMSep 2026
- -$39M-113.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -3.4% | +2301.4% | +2304.8 pp |
| 1 year | +44.9% | +21.0% | -24.0 pp |
| 3-year CAGR | +31.7% | +46.1% | +14.3 pp |
| 5-year CAGR | +27.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 238.4M USD
- Year-over-year change
- +44.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 238.4M | +44.9% |
| FY2024 | 2024-12-31 | 164.5M | -60.7% |
| FY2023 | 2023-12-31 | 418.2M | +301.0% |
| FY2022 | 2022-12-31 | 104.3M | +7550.0% |
| FY2021 | 2021-12-31 | (1.4M) | — |
EBITDA vs competitors
How CLMT compares with its peers on the latest reported figures
- CLMT's LTM Sep 2026 EBITDA of -$39M is the 8th highest of the 11 companies compared; the peer median is $160.46M.
- Its year-over-year change of -113.4% is the 8th highest of 11, against a peer median of -13.8%.
- EBITDA amounts to 0.8% of revenue for CLMT, versus a peer median of 14.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $1.27B | +15.5% | +9.0% | 16.0% | |
| LTM Jun 2026 | $735.21M | -5.9% | +15.8% | 26.8% | |
| LTM Jun 2026 | $690M | -14.9% | +13.9% | 19.0% | |
| LTM Sep 2026 | $232.84M | +46.9% | +6.3% | 11.5% | |
| LTM Jun 2026 | $181M | -12.7% | -7.0% | 9.8% | |
| LTM Mar 2026 | $139.93M | -27.5% | -10.3% | 6.0% | |
| LTM Sep 2026 | $136.5M | -4.9% | -56.0% | 12.1% | |
| LTM Sep 2026 | -$39M | -113.4% | +31.7% | 0.8% | |
| LTM Mar 2026 | -$42.1M | -2075.7% | — | 38.2% | |
| LTM Jun 2026 | -$166M | -151.6% | -34.7% | 2.9% | |
| LTM Jun 2026 | -$300.15M | -303.2% | — | 39.6% | |
| Peer median (excluding CLMT) | $160.46M | -13.8% | -0.3% | 14.0% | |
Competitors are the stored peer set for CLMT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.15B | 4.69B | 4.18B | 4.19B | 4.14B |
| Cost of Revenue | 3.01B | 4.33B | 3.73B | 3.96B | 3.89B |
| Gross Profit | 142.9M | 351.7M | 451.7M | 230.8M | 245.7M |
| Gross Margin | 4.5% | 7.5% | 10.8% | 5.5% | 5.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 203.9M | 197.3M | 187.9M | 201.2M | 171.7M |
| Operating Expenses | 228.5M | 219.8M | 184.5M | 222.7M | 191.5M |
| Depreciation & Amortization | 107.7M | 98.3M | 146.8M | 149M | 148.8M |
| EBITDA | (1.4M) | 104.3M | 418.2M | 164.5M | 238.4M |
| EBITDA Margin | -0.0% | 2.2% | 10.0% | 3.9% | 5.8% |
| Operating Income | (85.6M) | 131.9M | 267.2M | 8.1M | 54.2M |
| Operating Margin | -2.7% | 2.8% | 6.4% | 0.2% | 1.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 149.5M | 175.9M | 221.7M | 236.7M | 216M |
| Other Income / Expenses | (173M) | (301.8M) | (217.5M) | (229.3M) | (180.6M) |
| Income Before Tax | (258.6M) | (169.9M) | 49.7M | (221.2M) | (126.4M) |
| Pre-Tax Margin | -8.2% | -3.6% | 1.2% | -5.3% | -3.1% |
| Income Tax Expense | 1.5M | 3.4M | 1.6M | 800K | (92.6M) |
| Net Income | (254.9M) | (169.8M) | 48.1M | (222M) | (33.8M) |
| Net Margin | -8.1% | -3.6% | 1.2% | -5.3% | -0.8% |
| EPS (Basic) | (3.23) | (2.14) | 0.59 | (2.67) | (0.39) |
| EPS (Diluted) | (3.23) | (2.14) | 0.59 | (2.67) | (0.39) |
| Weighted Avg Shares | 78.98M | 79.34M | 80.08M | 83.15M | 86.76M |
| Weighted Avg Shares (Diluted) | 78.98M | 79.34M | 80.08M | 83.15M | 86.76M |
Calumet, Inc.
NASDAQ:CLMT
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.